Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
UTMB Collaborates on Program Targeting Potential Bioterrorist Pathogens Medical Countermeasures March 6, 2014 …
JPM-MCS Announces Start of Phase I Trial for Ebola Therapeutic Medical Countermeasures February 26, 2014 …
Social Norms Strongly Influence Pediatric Vaccination Decisions Medical Countermeasures February 14, 2014 …
Promising Class of Antibiotics Discovered for Drug-Resistant Tuberculosis Antimicrobial Resistance February 5, 2014 …
Combating MRSA: Phase 1 Trial Starts for Novel Antibiotic Antimicrobial Resistance January 31, 2014 …
